List of Certificates of Suitability (CEPs) for cep_2021_309___rev_01 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

Question

Looking for Certificates of Suitability (CEPs) for CEP 2021-309 - Rev 01 of Wavelength Enterprises Ltd. Petah Tikva Il

score 20 · Accepted Answer

Wavelength Enterprises Ltd. Petah Tikva Il, based in France, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

They are recognized for Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

One of their significant offerings is Cetirizine dihydrochloride, Process B, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2021-309 - Rev 01

This Chemical Type CEP, issued on May 22, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

Substance Number 1084 associated with this CEP further emphasizes

List of Certificates of Suitability (CEPs) for cep_2021_309___rev_01 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

Seqens

VISIT THE VIRTUAL BOOTH

Review portfolio & marketing content

CONTACT DETAILS

Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

PRESENTATION(s)

VIDEO(s)

DIGITAL CONTENT

2 INTERVIEW #SpeakPharma

11 CORPORATE CONTENT #SupplierSpotlight

2 DATA COMPILATION #PharmaFlow

62 NEWS #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

DEVELOPMENTS

1 Drugs in Development

KEY PRODUCTS

SERVICES

Analytical

API Manufacturing

API & Drug Product Development

KEY SERVICES

EXCIPIENTS

EXCIPIENTS BY INGREDIENTS

EXCIPIENTS BY APPLICATIONS

INSPECTIONS & REGISTRATIONS

Filters

CEP 2021-309 - Rev 01

Valid

Chemical

2024-05-22

1084

01

Looking for Certificates of Suitability (CEPs) for CEP 2021-309 - Rev 01 of Wavelength Enterprises Ltd. Petah Tikva Il